SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCSRT.L Regulatory News (CSRT)

  • There is currently no data for CSRT

Form 8.3 - CSR PLC - Replacement

28 Nov 2014 11:31

The issuer advises that the following replaces the BARCLAYS PLC Form 8.3 - CSR PLC announcement released on 27 November 2014 at 14.53 GMT.

The ticker information has been corrected to reference the information for the company CSR Plc instead of that of Consort Medical, which was erroneously included and should be disregarded.

All other details remain unchanged.

The full corrected version is shown below.

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Identity of the person whose positions/dealings Barclays PLC.
are being disclosed:
(b) Owner or controller of interest and short
positions disclosed, if different from 1(a):
(c) Name of offeror/offeree in relation to whose

CSR PLC

relevant securities this form relates:
(d) If an exempt fund manager connected with an
offeror/offeree, state this and specify identity of
offeror/offeree:
(e) Date position held/dealing undertaken: 26 November 2014
(f) Has the discloser previously disclosed, or are NO
they today disclosing, under the Code in respect
of any other party to this offer?

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: ORD
Interests Short Positions
Number (%) Number (%)
(1) Relevant securities owned
and/or controlled: 4,887,599 2.94% 122,884 0.07%
(2) Derivatives (other than
options): 126 0.00% 3,362,849 2.03%
(3) Options and agreements to
purchase/sell: 0 0.00% 0 0.00%
(4)
TOTAL: 4,887,725 2.94% 3,485,733 2.10%

All interests and all short positions should be disclosed.

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other executive options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

(a) Purchases and sales

Class of relevant Purchase/sale Number of Price per unit
security securities
ORD Purchase 100 8.2350 GBP
ORD Purchase 248 8.2300 GBP
ORD Purchase 293 8.2275 GBP
ORD Purchase 376 8.2600 GBP
ORD Purchase 708 8.2500 GBP
ORD Purchase 1,118 8.2498 GBP
ORD Purchase 1,227 8.2467 GBP
ORD Purchase 1,263 8.2531 GBP
ORD Purchase 1,569 8.2450 GBP
ORD Purchase 2,328 8.2436 GBP
ORD Purchase 4,881 8.2405 GBP
ORD Purchase 5,347 8.2429 GBP
ORD Purchase 6,086 8.2603 GBP
ORD Purchase 6,097 8.2513 GBP
ORD Purchase 10,762 8.2394 GBP
ORD Sale 44 8.1950 GBP
ORD Sale 124 8.2300 GBP
ORD Sale 293 8.2275 GBP
ORD Sale 305 8.2500 GBP
ORD Sale 390 8.2600 GBP
ORD Sale 1,846 8.2400 GBP
ORD Sale 1,995 8.2514 GBP
ORD Sale 10,317 8.2364 GBP
ORD Sale 19,920 8.2405 GBP

(b) Derivatives transactions (other than options)

Class of Product Nature of dealing Number of Price per
relevant description reference unit
security securities
ORD SWAP Long 2,372 8.2382 GBP
ORD CFD Long 2,777 8.2386 GBP
ORD CFD Long 7,431 8.2362 GBP
ORD CFD Short 1,118 8.2498 GBP
ORD SWAP Short 1,482 8.2488 GBP
ORD SWAP Short 2,212 8.2479 GBP
ORD CFD Short 5,347 8.2429 GBP
ORD SWAP Short 6,086 8.2604 GBP
ORD CFD Short 5,235 8.2532 GBP

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type

e.g. American, European etc.

Expiry date Option money paid/ received per unit

(ii) Exercising

Class of relevant security Product description

e.g. call option

Number of securities Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing

e.g. subscription, conversion

Details Price per unit (if applicable)

The currency of all prices and other monetary amounts should be stated.

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state “none”

NONE

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

NONE

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 27 Nov 2014
Contact name: Sushil Vashisht
Telephone number: 0207 773 0744

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Copyright Business Wire 2014

Date   Source Headline
18th Jul 201410:21 amRNSDirector/PDMR Shareholding
16th Jul 20147:00 amRNSDirector/PDMR Shareholding
14th Jul 20147:00 amRNSDirectorate Change
1st Jul 20143:46 pmRNSTotal Voting Rights
26th Jun 201410:37 amRNSHolding(s) in Company
24th Jun 20144:15 pmRNSHolding(s) in Company
23rd Jun 20144:28 pmRNSDirector/PDMR Shareholding
23rd Jun 20144:23 pmRNSDirector/PDMR Shareholding
19th Jun 20142:42 pmRNSDirector/PDMR Shareholding
17th Jun 20147:00 amRNSFinal results for the year ended 30 April 2014
4th Jun 20147:00 amRNSDirector Declaration
2nd Jun 20143:16 pmRNSBlocklisting Interim Review
22nd May 20147:00 amRNSChange of Adviser
16th May 201410:39 amRNSHolding(s) in Company
13th May 20147:00 amRNSKing Systems Milestone Payment
14th Apr 20144:58 pmRNSBlocklisting Interim Review
3rd Apr 201411:15 amRNSHolding(s) in Company
1st Apr 20147:00 amRNSDirector Declaration
19th Mar 20147:00 amRNSInterim Management Statement
3rd Mar 20149:00 amRNSTotal Voting Rights
6th Feb 201410:24 amRNSHolding(s) in Company
5th Feb 20142:45 pmRNSHolding(s) in Company
3rd Feb 20147:00 amRNSFDA Approval of Development Programme
28th Jan 20149:43 amRNSHolding(s) in Company
3rd Jan 20149:15 amRNSTotal Voting Rights
31st Dec 20139:34 amRNSHolding(s) in Company
4th Dec 20137:00 amRNSInterim results for the six months to 31/10/13
2nd Dec 20134:15 pmRNSBlocklisting Interim Review
2nd Dec 20134:14 pmRNSTotal Voting Rights
28th Nov 20137:00 amRNSBespak Supply Contract Award
20th Nov 20131:37 pmRNSJefferies 2013 Global Healthcare Conference
15th Nov 20131:54 pmRNSDirector Declaration
4th Nov 20133:37 pmRNSHolding(s) in Company
1st Nov 20137:00 amRNSTotal Voting Rights
31st Oct 201312:21 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
14th Oct 20134:09 pmRNSBlocklisting Interim Review
14th Oct 20133:58 pmRNSHolding(s) in Company
11th Oct 201312:08 pmRNSHolding(s) in Company
10th Oct 20133:32 pmRNSHolding(s) in Company
30th Sep 20133:26 pmRNSTotal Voting Rights
27th Sep 201310:17 amRNSDirector/PDMR Shareholding
6th Sep 20131:51 pmRNSHolding(s) in Company
5th Sep 20131:39 pmRNSDirector/PDMR Shareholding
3rd Sep 201310:15 amRNSResult of AGM
2nd Sep 20137:00 amRNSInterim Management Statement
26th Jul 20132:52 pmRNSPosting of Annual Report and Notice of AGM
24th Jul 20132:43 pmRNSDirector/PDMR Shareholding
22nd Jul 20137:00 amRNSBespak development contract award
27th Jun 201312:27 pmRNSBlocklisting
25th Jun 20134:11 pmRNSBlocklisting Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.